(Q37048418)

17 August 2017

1 reference

title

HDL heterogeneity and coronary heart disease (English)

1 reference

17 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

2 December 2022

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

2 December 2022

author name string

C. Fievet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1817000

2 December 2022

J. C. Fruchart

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1817000

2 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1817000

2 December 2022

publication date

1 September 1991

1 reference

full work available at URL

17 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fdmr.5610070304

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

http://onlinelibrary.wiley.com/wol1/doi/10.1002/dmr.5610070304/fullpdf

2 December 2022

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Diabetes/metabolism reviews

2 December 2022

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

3

1 reference

17 August 2017

page(s)

155-162

1 reference

High-density lipoprotein--the clinical implications of recent studies

17 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Plasma high density lipoproteins. Metabolism and relationship to atherogenesis

2 December 2022

2

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Ultracentrifugal studies of high density serum lipoproteins in clinically healthy adults

2 December 2022

6

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Chromatofocusing of human high density lipoproteins and isolation of lipoproteins A and A-I

2 December 2022

8

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Characterization of human high-density lipoproteins by gradient gel electrophoresis

2 December 2022

10

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Particle distribution of human serum high density lipoproteins

2 December 2022

13

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Nondenaturing polyacrylamide gradient gel electrophoresis

2 December 2022

14

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Heterogeneity of human serum high-density lipoprotein (HDL 2 ).

2 December 2022

16

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Apoliproproteins and lipoproteins

2 December 2022

18

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Polypeptide distribution of the main lipoprotein density classes separated from human plasma by rate zonal ultracentrifugation

2 December 2022

19

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Subpopulations of apolipoprotein A-I in human high-density lipoproteins. Their metabolic properties and response to drug therapy

2 December 2022

21

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein

2 December 2022

27

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Heterogeneity of human high density lipoprotein: presence of lipoproteins with and without apoE and their roles as substrates for lecithin:cholesterol acyltransferase reaction

2 December 2022

30

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency

2 December 2022

32

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Protein-lipid relationships in human plasma. II. In atherosclerosis and related conditions.

2 December 2022

38

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

2 December 2022

40

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts. Lipid and nonlipid factors

2 December 2022

41

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

High density lipoprotein and coronary heart disease

2 December 2022

44

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

The lipoproteins: predictors, protectors, and pathogens.

2 December 2022

45

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Rapid activation of human platelets by low concentrations of low-density lipoprotein via phosphatidylinositol cycle

2 December 2022

47

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Inhibition of cholesterol crystal formation by apolipoproteins in supersaturated model bile

2 December 2022

48

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis

2 December 2022

49

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins

2 December 2022

51

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles

2 December 2022

55

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Apolipoprotein A-I containing lipoproteins in coronary artery disease

2 December 2022

56

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

A cholesteryl ester transfer complex in human plasma

2 December 2022

57

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Alcohol-induced changes in serum lipoproteins and in their metabolism.

2 December 2022

62

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men

2 December 2022

65

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Hyperlipidemia in diabetes mellitus.

2 December 2022

66

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Glucosylation of low-density lipoproteins to an extent comparable to that seen in diabetes slows their catabolism.

2 December 2022

67

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Nonenzymatic Glycosylation of HDL and Impaired HDL-Receptor–Mediated Cholesterol Efflux

2 December 2022

68

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Evaluation of apolipoprotein A-I containing particles in chronic renal failure patients undergoing hemodialysis

2 December 2022

70

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition

2 December 2022

71

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceridemic patients

2 December 2022

72

1 reference

https://api.crossref.org/works/10.1002/DMR.5610070304

2 December 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1817000

2 December 2022

1 reference